The EMA has started a review of Leo Pharma’s interleukin-13 inhibitor tralokinumab as an antibody therapy for atopic dermatitis, a category that is currently dominated by Sanofi and Regeneron ...

Get insights into top dividend stock picks for 2025 from Barron’s Roundtable, with potential gains ranging from 19.46% to ...

The ROTH Conference provides investors the opportunity to hear from and meet with executive management from approximately 500 private and public companies in a variety of growth sectors. The Company ...

Become empowered in how you approach your romantic relationship, dear Leo. While you aren’t responsible for what your partner brings into your connection, it doesn’t mean that you can’t ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.